Foghorn Therapeutics FHTX
NASDAQ FHTX
$3.52 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Foghorn Therapeutics (FHTX) EBT Margin (2020 - 2026)

Updated

Foghorn Therapeutics (FHTX) recorded EBT Margin of -44.77% in Q2 2026, up 203.84 percentage points from -248.62% a year earlier and up 562.24 percentage points from the prior quarter.

Analysis

Foghorn Therapeutics (FHTX) EBT Margin (2020 - 2026) Analysis & Trends

On a TTM basis, Foghorn Therapeutics' EBT Margin came in at -178.73% as of Jun 30, 2026, up 142.43 percentage points year-over-year; for FY2025, it came in at -251.20%, up 132.04 percentage points from FY2024.

  • Annual EBT Margin has a five-year change of +15913.91 percentage points (FY2020 to FY2025).
  • Across earlier years, EBT Margin came in at -383.24% in FY2024 (-107.44 pp), -275.80% in FY2023 (+290.47 pp), -566.27% in FY2022 (+7210.91 pp) and -7777.18% in FY2021 (+8387.94 pp).
  • The Q2 2026 figure is the highest quarterly EBT Margin in data going back to Q3 2020.
  • On a year-over-year basis, EBT Margin rose in five of the last eight quarters, with an average year-over-year change of +24.60 percentage points.
  • Peak year-over-year performance for EBT Margin in the last five years was a gain of 64879.85 percentage points in Q3 2022, against a drop of 54826.39 percentage points in Q3 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at -607.01% (Q1 2026), -239.71% (Q4 2025) and -202.00% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 26.66%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 25.18%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -4.11%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 29.63%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 18.19%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 27.53%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -131.41%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -4.34%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 41.75%
10 Foghorn Therapeutics 206.67 Mn -119.28 Mn - -44.77%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -44.77%
Mar 31, 2026 -607.01%
Dec 31, 2025 -239.71%
Sep 30, 2025 -202.00%
Jun 30, 2025 -248.62%
Mar 31, 2025 -339.73%
Dec 31, 2024 -682.88%
Sep 30, 2024 -244.90%
Jun 30, 2024 -333.61%
Mar 31, 2024 -495.37%
Dec 31, 2023 -383.43%
Sep 30, 2023 -77.85%
Jun 30, 2023 -509.82%
Mar 31, 2023 -563.72%
Dec 31, 2022 -690.39%
Sep 30, 2022 -388.44%
Jun 30, 2022 -608.31%
Mar 31, 2022 -686.58%
Dec 31, 2021 -3,998.32%
Sep 30, 2021 -65,268.29%
API Access

Foghorn Therapeutics EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=FHTX&period=max&api_key=YOUR_API_KEY